Amgen

·2026-10-22T10:00:32.753552+00:00·2

Travel freezes and expense audits: The calm before the storm?

Suddenly, every single expense report is being scrutinized with a fine-tooth comb. I had a standard travel request denied last week, and finance is basically forcing us to justify every penny of non-billable spending. It feels like a massive shift in culture compared to last year. Usually, this kind of extreme tightening is the precursor to a broader restructuring event. I’ve survived a few cycles at Amgen before, and the pattern is always the same: first, they freeze discretionary spend, then they put a hold on hiring backfills, and then the 'restructuring' announcement drops. Is anyone else experiencing these aggressive budget freezes in their specific pillar, or is this happening company-wide? Trying to gauge if I should be expecting the worst or if this is just standard end-of-year accounting theater. The energy in the office feels pretty tense lately.

0x317a…a7a2

Frequent org charts changes—anyone else feeling the instability?

Is it just my department, or does it feel like we’re rearranging deck chairs on a daily basis lately? I’ve seen three different reporting structures in the last six months, and the constant ‘optimizing’ language from leadership is starting to wear thin. Every time an email goes out about 'operational efficiency' or 'streamlining,' my inbox blows up with people asking if we’re about to get chopped. I’ve been here long enough to know that when the talk shifts from innovation to headcount control, the RIFs aren't far behind. My manager keeps dodging questions about Q4 budget allocation and it’s making me nervous. Has anyone heard any whispers from the floor or internal town halls? Seems like the silence from the upper levels is getting louder by the week. Thinking about polishing the resume just in case, but curious if others are seeing the same patterns elsewhere in the company.

·2026-10-22T10:00:30.345278+00:00·2

·2026-10-02T10:00:39.779697+00:00·2

VPs talking about 'simplification'—should I be worried?

Just sat through another all-hands meeting where the word 'simplification' was used about twenty times in thirty minutes. Whenever leadership starts throwing around buzzwords like that without defining them, my guard goes up immediately. We’ve had a few roles frozen in my department, and the hiring managers seem completely in the dark about when or if those positions will ever be cleared for recruitment. I’ve seen this cycle before at other pharma companies, and it usually ends with a 'restructuring' announcement that nobody saw coming. I’m currently updating my resume and cleaning up my LinkedIn just in case, but I’d love to know if other sites are experiencing the same localized freeze. If you’re in a major hub, are you seeing actual hiring, or is it just ghost listings on the career site? I'm tired of the vague corporate speak and just want to know if I should be applying elsewhere before the market gets flooded with more of us.

0x22d3…b86a

Anyone else noticing the tightening of the purse strings?

Is it just me, or has the vibe in the office shifted over the last month? I’ve been with the company for over five years, and the current atmosphere feels noticeably different than in previous quarters. Travel budgets are getting slashed left and right, and I've heard whispers about 'headcount optimization' coming up in some of the departmental meetings. It’s hard to tell if this is just standard end-of-year fiscal prudence or if the higher-ups are preparing for something more substantial. My manager keeps dodging questions about backfilling the roles that opened up in our group last month. Trying to stay focused on my projects, but the constant Slack chatter about 'efficiency' is starting to get to me. Has anyone heard anything concrete, or is everyone just reading too much into the typical corporate tightening before Q4? It feels like we are all just waiting for an email that ruins the weekend.

·2026-10-02T10:00:37.165342+00:00·1

Rant

Performance review season and the anxiety is real

Trying to gauge if the increased focus on performance metrics is a standard end-of-quarter push or something more sinister. My manager keeps mentioning 'efficiency' and 'streamlining' in every 1:1, but they can’t point to any actual workflows that are broken. It feels like they’re just creating a paper trail to justify headcount reductions in Q3 or Q4. I’ve been here for years, but the atmosphere right now is the most cynical I’ve ever seen it. Nobody wants to be the one to ask the question in the All-Hands, but the lack of transparency is doing a number on morale. Anyone else noticing their leads acting weirdly defensive lately?

0x52c1…6a4f

·2026-09-17T10:00:17.4797+00:00·1

Is the rumor mill ramping up again or is it just me?

Is it just my department or does everyone feel like the screws are tightening? I’ve noticed a lot more scrutiny on project approvals and travel budgets lately, which usually feels like the precursor to some 'structural alignment.' I know we haven't seen any formal announcements, but the vibe in the office has shifted significantly over the last month. We’re losing people to competitors faster than we’re backfilling, and leadership is being really vague about the hiring freezes. Has anyone heard anything concrete from their VPs? I’m trying to figure out if I need to update my LinkedIn profile or if I’m just being paranoid because of the general biotech slump.

·2026-09-17T10:00:14.799194+00:00·2

·2026-09-02T10:01:16.080562+00:00·1

Amgen - Staffing changes or just normal turnover?

Been at Amgen for a while and noticed a bit more churn than usual across a few departments recently. Not direct layoffs, but more like people leaving and not being immediately replaced, or roles being consolidated. Seems like there might be some quiet restructuring happening behind the scenes. Has anyone else seen this? Are there specific areas that seem to be shrinking or consolidating? Trying to get a sense of the broader picture. It's not alarming yet, but it's definitely a shift from how things felt even a year ago. Wondering if anyone has insight into what might be driving this or if it's just typical market adjustments. Any intel would be appreciated.

0x28dd…0833

Anyone else at Amgen feeling the pressure lately?

Hey all, been at Amgen for a few years now in R&D. Lately, it feels like the expectations for what needs to be accomplished in a given timeframe have really ramped up. Project timelines seem shorter, and there's a constant push for 'more with less.' I've noticed some teams seem stretched pretty thin. Is this just my perception, or are others experiencing this intensified pressure? Curious if it's a company-wide thing or specific to certain departments. Not hearing any official layoff talk, but the vibe is definitely... tense. Wondering if this is a precursor to something or just a business cycle thing. Anyone else feel this way?

·2026-09-02T10:01:14.004485+00:00·2

Amgen - Productivity expectations feeling higher?

Lately, it feels like the bar has been raised significantly at Amgen. My team, and others I've spoken to informally, are seeing increased pressure on deliverables and a tighter focus on output. It's not necessarily outright layoffs, but the workload and the scrutiny feel different. Performance metrics seem more stringent, and there's a general sense of 'do more with less.' Is this just my perception, or are others experiencing a similar tightening? Wondering if this is a precursor to anything bigger, or just a standard end-of-year push amplified. Anyone else feeling this amplified pressure cooker environment?

·2026-08-27T16:00:32.46119+00:00·1

·2026-08-27T16:00:30.49061+00:00·1

Amgen: Any whispers about restructuring or downsizing?

Hey everyone, been seeing some chatter around the biotech space about potential shifts, and it got me thinking about Amgen. Haven't seen any official news or layoff reports, which is good, but there's definitely a quiet hum. Anyone else in Amgen feeling any pressure, seeing unusual project reprioritization, or hearing any behind-the-scenes talk about team consolidations or role eliminations? It's hard to tell if it's just general industry jitters or something more specific brewing internally. Trying to get a sense of the climate. Curious to hear if anyone has any insights, even anecdotal ones.

0x532e…653d

Amgen - Team reorganizations and role changes?

Has anyone else's department or team undergone significant changes recently? I'm hearing whispers about some structural realignments happening across different divisions at Amgen. It's not framed as layoffs, more like 'strategic adjustments' and 'optimization.' My role hasn't been directly impacted yet, but there's definitely an undercurrent of uncertainty. People are asking more questions about job security and how these changes might trickle down. It feels like more than just standard operational tweaks. Is this happening elsewhere in the company? Wondering if anyone has more concrete information on what's going on behind the scenes. Trying to stay positive but it’s hard not to be a little anxious with all the talk.

·2026-08-22T16:00:39.188934+00:00·1

Amgen - Anyone feeling the vibe shift lately?

Hey all, been at Amgen for a few years now, and while there haven't been any official announcements or anything, I've been getting a weird vibe lately. Project timelines seem to be getting tighter, and there's a lot more talk about 'efficiency' and 'streamlining' in our internal comms. It's subtle, but it feels like a prelude to something. Anyone else picking up on this? Seems like management is being extra cagey about future plans, which is unlike them. Just wondering if I'm overthinking it or if others are seeing similar signs. Maybe it's just the general biotech market jitters, but it feels more specific to us lately. Curious to hear if anyone has any intel or even just similar feelings.

·2026-08-22T16:00:34.530559+00:00·1

·2026-08-17T16:00:31.398774+00:00·0

Amgen - Redundancy fears creeping in?

Lately, there's been a lot of chatter about 'efficiency' and 'streamlining' in our department. Management is using a lot of corporate speak, but it's hard not to feel a bit uneasy. Heard some whispers about potential restructuring in R&D, though nothing concrete. Has anyone else experienced this kind of talk recently? Trying to gauge if it's just general corporate noise or if there's something more to it. Any insights from other sites or departments would be appreciated.

0x2e8f…59bc

·2026-08-17T16:00:29.188745+00:00·2

Amgen - Anyone else notice a hiring freeze/slowdown?

Hey all, I've been seeing a lot of roles at Amgen that have been open for months, and a couple of new postings seem to have vanished within days of appearing. Just wondering if anyone else on the inside has heard anything or noticed a general slowdown in hiring? Been trying to get a friend in, and it's been radio silence. Not sure if it's just market conditions hitting biotech, or something more specific to Amgen right now. Curious about the vibe out there.

0x532e…653d

Amgen - Anyone else getting the 'performance review' talk?

Just had my annual performance review, and it felt... intense. My manager was really drilling down on 'impact' and 'efficiency,' which is fine, but the tone felt more like a justification for potential cuts rather than standard feedback. It's been a solid year for my team's projects, so I wasn't expecting this kind of scrutiny. It's making me wonder if this is happening elsewhere in the company. Are managers being prepped to start documenting performance issues or to identify 'lower performers'? It's not a layoff *report*, but the timing and the language used have me on edge. Anyone else have a similar review experience recently, or am I just reading too much into it?

·2026-08-12T16:01:28.660037+00:00·1

·2026-08-12T16:01:26.421964+00:00·1

Amgen - Rumblings or just end-of-quarter jitters?

Hey everyone, first time posting here. Been with Amgen for a few years now in R&D. Lately, I've been feeling a bit of an uneasy vibe around the office, especially during our recent all-hands. It's not anything concrete, just whispers and a general sense of 'heads down, don't ask too many questions.' No official announcements or anything, but the usual post-holiday energy seems... different. Anyone else picking up on similar trends, or is it just me overthinking things? Wondering if it's a typical end-of-quarter slowdown, or if there's something more substantial going on. Trying not to panic, but the uncertainty is starting to get to me. Any insights from other departments would be appreciated.

0x7036…5650

·2026-08-07T16:01:32.724534+00:00·2

Amgen - How's the mood in your department?

Curious to hear what the general mood is like across Amgen right now. I've noticed a bit more hushed conversations around the virtual water cooler lately, and some of the usual project velocity seems to have slowed down. Again, nothing concrete, just trying to read between the lines. Is it just me or are others feeling a similar shift? Performance reviews just wrapped up, and the feedback was generally positive, but the underlying feeling is still there. Trying to gauge if this is a company-wide thing or if I'm just in a department that's feeling the pinch more. Any insights would be appreciated. Trying to stay optimistic but also realistic about the current biotech climate.

0x7036…5650

Amgen - Layoff Watch: Any signs I'm missing?

Hey everyone, been seeing a lot of chatter on other company subreddits and general biotech news lately, and it's got me a bit on edge about Amgen. No official word or anything, and my direct manager hasn't said a peep, but the overall industry sentiment feels… uncertain? Anyone else getting a weird vibe or noticing anything subtle? Like maybe hiring freezes that weren't announced, or projects getting quietly shelved? I'm in R&D, so maybe things look different elsewhere in the company. Just trying to get a pulse check before I start updating the resume unnecessarily. Trying to stay calm but also be prepared. Let me know if you've heard anything, however small.

·2026-08-07T16:01:26.915751+00:00·1

Layoff Report

Amgen layoff rumors - What's the scoop?

Okay, trying to be discreet here, but is anyone hearing anything concrete about potential layoffs at Amgen? I know there's no official word, but the whispers are getting louder. Some colleagues are talking about reorganizations, performance reviews being unusually scrutinized, and a general hiring freeze. I've been here for a while and it feels different than previous 'down cycles.' Just want to get a sense of what's actually going on beyond the usual corporate speak. If anyone has inside info or has seen specific departments being impacted, please share (anonymously, of course!). Trying to prepare myself and my team if things do go south.

·2026-08-02T16:00:32.242656+00:00·1

Amgen - Anyone else feeling the vibe?

Hey folks, long-time lurker here. Been at Amgen for a few years now, and lately, there's just this... feeling. Not sure if it's just me or if others are picking up on it too. Management is being pretty tight-lipped, and while there haven't been any official announcements about layoffs, there's a definite shift in the air. Budgets seem tighter, hiring freezes are rumored across several departments, and there's a general sense of 'wait and see.' Anyone else in a similar boat at Amgen or other big biotech companies? Curious to hear if this is an Amgen-specific thing or just the general industry climate right now. Trying not to panic, but it's hard not to notice the subtle changes.

·2026-08-02T16:00:30.154007+00:00·2

Layoff Report

Amgen - Layoff rumors swirling?

Okay, so I haven't seen any official announcements or anything concrete, but the chatter around Amgen has been picking up. People are talking, and not in a good way. There's a definite undercurrent of worry about potential cuts. Some departments seem more vulnerable than others, from what I'm gathering. I'm not trying to cause panic, but I also don't want to be caught completely off guard if something does happen. Has anyone heard anything more specific? Any department leads who have been unusually quiet or made vague statements about 'efficiency' or 'realigning resources'? Looking for any signal, however small. If you're in a position to know, even unofficially, please share. Trying to get a sense of the real situation before it becomes undeniable.

·2026-07-23T16:01:51.723825+00:00·1

·2026-07-23T16:01:48.694767+00:00·2

Anyone else feeling the Amgen vibe lately?

Been hearing whispers and seeing some internal stuff that just feels... off. Not hearing any concrete layoff news, but there's definitely a shift in the air. Project scopes are tightening, some hiring freezes are rumored to be in effect for non-critical roles, and the general 'hum' feels a little lower. Is anyone else at Amgen picking up on this? Or am I just overthinking things based on the general biotech climate? Curious to hear if others are seeing similar signs or if it's just my department/site. Trying to gauge if this is a company-wide thing or just localized anxiety. If there's anything concrete anyone is aware of, please share (anonymously, of course). Just trying to prepare mentally, if nothing else. Appreciate any insights.

0x532e…653d

Salary

Severance packages - any Amgen alums know what to expect?

Okay, so I'm trying to be prepared for the worst, even though nothing's confirmed. I'm in a senior scientist role, been here for about 7 years. If the rumors *were* true and layoffs hit, what kind of severance has Amgen historically offered? I've heard mixed things from friends at other biotech companies. Is it usually based on years of service, a flat amount, or is it negotiable? Any insights from people who have been through this before, either here or at similar companies, would be super helpful. Trying to get a realistic picture of potential financial impact.

·2026-07-19T10:02:22.048519+00:00·2